Genmab — November 2018
-
-
Mit regnstykke ser således ud, og det er jeg rimelig komfortabel med.415 mill. dkr (Dara Salg) + 83 mill dkr (Dara salgsmilestone) + 3 mill ( Ofa. Salg) 60 mill dkr ( Reimbursement income )
i alt Revenue 561 mill dkr. Plus evt overraskelser i q2 var der 2 gange milestone 40 mill. Dkr. Som ikke var offentliggjorte -
Ny analysevideo med Genmab: http://www.proinvestor.com/debat/76485
-
næhhh det er han ikke, men hvor meget kan man egentligt bruge TA i biotek?
-
ja, tor også at det vil været ret vigtigt på den korte bane, at vi når de 2 milliarder dollars i dara salg, ellers får vi ikke den store milestone før om et år
-
tror
-
men er ret overbevist om, at det lige går
-
tak for link, lidt betryggende at de har 2,055 mia $ i salg af darzalex i 2018
-
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind